nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—RRM2—uterine cancer	0.483	1	CbGaD
Cladribine—SLC22A2—Progesterone—uterine cancer	0.0647	0.294	CbGbCtD
Cladribine—SLC22A1—Progesterone—uterine cancer	0.0562	0.255	CbGbCtD
Cladribine—ABCG2—Dactinomycin—uterine cancer	0.0378	0.172	CbGbCtD
Cladribine—ABCG2—Carboplatin—uterine cancer	0.0254	0.116	CbGbCtD
Cladribine—ABCG2—Etoposide—uterine cancer	0.0214	0.0971	CbGbCtD
Cladribine—ABCG2—Doxorubicin—uterine cancer	0.0146	0.0662	CbGbCtD
Cladribine—NR5A1—corpus luteum—uterine cancer	0.0129	0.155	CbGeAlD
Cladribine—POLE4—renal system—uterine cancer	0.00219	0.0265	CbGeAlD
Cladribine—POLE2—endometrium—uterine cancer	0.00185	0.0224	CbGeAlD
Cladribine—POLE2—mammalian vulva—uterine cancer	0.00179	0.0216	CbGeAlD
Cladribine—POLE4—female reproductive system—uterine cancer	0.00176	0.0212	CbGeAlD
Cladribine—Clofarabine—RRM2—uterine cancer	0.00163	1	CrCbGaD
Cladribine—RRM2B—myometrium—uterine cancer	0.00155	0.0187	CbGeAlD
Cladribine—POLE3—myometrium—uterine cancer	0.00146	0.0176	CbGeAlD
Cladribine—POLE2—female gonad—uterine cancer	0.0014	0.0169	CbGeAlD
Cladribine—POLE2—vagina—uterine cancer	0.00139	0.0168	CbGeAlD
Cladribine—PNP—renal system—uterine cancer	0.00121	0.0146	CbGeAlD
Cladribine—RRM2B—uterine cervix—uterine cancer	0.0012	0.0145	CbGeAlD
Cladribine—RRM2B—decidua—uterine cancer	0.00115	0.0138	CbGeAlD
Cladribine—POLE3—uterine cervix—uterine cancer	0.00114	0.0137	CbGeAlD
Cladribine—RRM2B—renal system—uterine cancer	0.00113	0.0136	CbGeAlD
Cladribine—POLE—myometrium—uterine cancer	0.00111	0.0135	CbGeAlD
Cladribine—RRM2B—endometrium—uterine cancer	0.00109	0.0131	CbGeAlD
Cladribine—POLE3—decidua—uterine cancer	0.00108	0.0131	CbGeAlD
Cladribine—PNP—uterus—uterine cancer	0.00108	0.013	CbGeAlD
Cladribine—POLE3—renal system—uterine cancer	0.00106	0.0128	CbGeAlD
Cladribine—RRM2B—mammalian vulva—uterine cancer	0.00105	0.0127	CbGeAlD
Cladribine—POLE3—endometrium—uterine cancer	0.00103	0.0124	CbGeAlD
Cladribine—POLE3—mammalian vulva—uterine cancer	0.000995	0.012	CbGeAlD
Cladribine—PNP—female reproductive system—uterine cancer	0.000971	0.0117	CbGeAlD
Cladribine—POLA1—myometrium—uterine cancer	0.000961	0.0116	CbGeAlD
Cladribine—SLC28A3—mammalian vulva—uterine cancer	0.000931	0.0112	CbGeAlD
Cladribine—RRM2—myometrium—uterine cancer	0.000918	0.0111	CbGeAlD
Cladribine—RRM2B—female reproductive system—uterine cancer	0.000901	0.0109	CbGeAlD
Cladribine—POLE2—lymph node—uterine cancer	0.000898	0.0108	CbGeAlD
Cladribine—PNP—female gonad—uterine cancer	0.000884	0.0107	CbGeAlD
Cladribine—POLE—uterine cervix—uterine cancer	0.000868	0.0105	CbGeAlD
Cladribine—POLE3—female reproductive system—uterine cancer	0.000852	0.0103	CbGeAlD
Cladribine—POLE—decidua—uterine cancer	0.000827	0.00998	CbGeAlD
Cladribine—NR5A1—female reproductive system—uterine cancer	0.000826	0.00997	CbGeAlD
Cladribine—RRM2B—female gonad—uterine cancer	0.00082	0.0099	CbGeAlD
Cladribine—RRM2B—vagina—uterine cancer	0.000815	0.00984	CbGeAlD
Cladribine—POLE—endometrium—uterine cancer	0.000785	0.00947	CbGeAlD
Cladribine—POLE3—female gonad—uterine cancer	0.000775	0.00936	CbGeAlD
Cladribine—POLE3—vagina—uterine cancer	0.000771	0.0093	CbGeAlD
Cladribine—RRM1—myometrium—uterine cancer	0.000763	0.00921	CbGeAlD
Cladribine—POLE—mammalian vulva—uterine cancer	0.000759	0.00916	CbGeAlD
Cladribine—NR5A1—female gonad—uterine cancer	0.000751	0.00907	CbGeAlD
Cladribine—POLA1—uterine cervix—uterine cancer	0.000748	0.00903	CbGeAlD
Cladribine—SLC28A3—female gonad—uterine cancer	0.000726	0.00876	CbGeAlD
Cladribine—RRM2—uterine cervix—uterine cancer	0.000714	0.00862	CbGeAlD
Cladribine—POLA1—decidua—uterine cancer	0.000712	0.0086	CbGeAlD
Cladribine—RRM2—decidua—uterine cancer	0.000681	0.00822	CbGeAlD
Cladribine—POLA1—endometrium—uterine cancer	0.000676	0.00816	CbGeAlD
Cladribine—RRM2—renal system—uterine cancer	0.000668	0.00807	CbGeAlD
Cladribine—POLA1—mammalian vulva—uterine cancer	0.000654	0.0079	CbGeAlD
Cladribine—POLE—female reproductive system—uterine cancer	0.00065	0.00785	CbGeAlD
Cladribine—RRM2—endometrium—uterine cancer	0.000646	0.0078	CbGeAlD
Cladribine—RRM2—mammalian vulva—uterine cancer	0.000625	0.00754	CbGeAlD
Cladribine—RRM2—uterus—uterine cancer	0.000595	0.00719	CbGeAlD
Cladribine—RRM1—uterine cervix—uterine cancer	0.000594	0.00716	CbGeAlD
Cladribine—DCK—myometrium—uterine cancer	0.000592	0.00715	CbGeAlD
Cladribine—POLE—female gonad—uterine cancer	0.000591	0.00714	CbGeAlD
Cladribine—POLE—vagina—uterine cancer	0.000588	0.0071	CbGeAlD
Cladribine—RRM1—smooth muscle tissue—uterine cancer	0.000577	0.00696	CbGeAlD
Cladribine—RRM1—decidua—uterine cancer	0.000565	0.00683	CbGeAlD
Cladribine—RRM1—renal system—uterine cancer	0.000555	0.0067	CbGeAlD
Cladribine—RRM1—endometrium—uterine cancer	0.000537	0.00648	CbGeAlD
Cladribine—RRM2—female reproductive system—uterine cancer	0.000535	0.00646	CbGeAlD
Cladribine—RRM2B—lymph node—uterine cancer	0.000527	0.00636	CbGeAlD
Cladribine—SLC22A2—renal system—uterine cancer	0.000521	0.00629	CbGeAlD
Cladribine—RRM1—mammalian vulva—uterine cancer	0.000519	0.00627	CbGeAlD
Cladribine—POLA1—female gonad—uterine cancer	0.00051	0.00615	CbGeAlD
Cladribine—POLA1—vagina—uterine cancer	0.000507	0.00612	CbGeAlD
Cladribine—POLE3—lymph node—uterine cancer	0.000498	0.00602	CbGeAlD
Cladribine—RRM1—uterus—uterine cancer	0.000495	0.00597	CbGeAlD
Cladribine—RRM2—female gonad—uterine cancer	0.000487	0.00588	CbGeAlD
Cladribine—RRM2—vagina—uterine cancer	0.000484	0.00584	CbGeAlD
Cladribine—DCK—uterine cervix—uterine cancer	0.000461	0.00556	CbGeAlD
Cladribine—RRM1—female reproductive system—uterine cancer	0.000445	0.00537	CbGeAlD
Cladribine—DCK—decidua—uterine cancer	0.000439	0.0053	CbGeAlD
Cladribine—DCK—endometrium—uterine cancer	0.000417	0.00503	CbGeAlD
Cladribine—RRM1—female gonad—uterine cancer	0.000405	0.00488	CbGeAlD
Cladribine—DCK—mammalian vulva—uterine cancer	0.000403	0.00487	CbGeAlD
Cladribine—RRM1—vagina—uterine cancer	0.000402	0.00485	CbGeAlD
Cladribine—POLE2—Teniposide—Etoposide—uterine cancer	0.000394	0.119	CbGdCrCtD
Cladribine—DCK—uterus—uterine cancer	0.000384	0.00464	CbGeAlD
Cladribine—POLE—lymph node—uterine cancer	0.00038	0.00459	CbGeAlD
Cladribine—SLC22A1—renal system—uterine cancer	0.000368	0.00444	CbGeAlD
Cladribine—DCK—female reproductive system—uterine cancer	0.000345	0.00417	CbGeAlD
Cladribine—ABCG2—myometrium—uterine cancer	0.00033	0.00399	CbGeAlD
Cladribine—POLA1—lymph node—uterine cancer	0.000328	0.00396	CbGeAlD
Cladribine—DCK—female gonad—uterine cancer	0.000314	0.00379	CbGeAlD
Cladribine—RRM2—lymph node—uterine cancer	0.000313	0.00378	CbGeAlD
Cladribine—DCK—vagina—uterine cancer	0.000312	0.00377	CbGeAlD
Cladribine—SLC22A1—vagina—uterine cancer	0.000266	0.00322	CbGeAlD
Cladribine—RRM1—lymph node—uterine cancer	0.00026	0.00314	CbGeAlD
Cladribine—ABCG2—uterine cervix—uterine cancer	0.000257	0.0031	CbGeAlD
Cladribine—ABCG2—decidua—uterine cancer	0.000245	0.00296	CbGeAlD
Cladribine—ABCG2—endometrium—uterine cancer	0.000233	0.00281	CbGeAlD
Cladribine—ABCG2—mammalian vulva—uterine cancer	0.000225	0.00272	CbGeAlD
Cladribine—PNP—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.000216	0.0654	CbGdCrCtD
Cladribine—ABCG2—uterus—uterine cancer	0.000214	0.00259	CbGeAlD
Cladribine—POLE2—Doxorubicin—Epirubicin—uterine cancer	0.000205	0.0622	CbGdCrCtD
Cladribine—POLE2—Daunorubicin—Epirubicin—uterine cancer	0.000205	0.0622	CbGdCrCtD
Cladribine—POLE2—Idarubicin—Epirubicin—uterine cancer	0.000205	0.0622	CbGdCrCtD
Cladribine—DCK—lymph node—uterine cancer	0.000202	0.00244	CbGeAlD
Cladribine—POLA1—Norethindrone—Progesterone—uterine cancer	0.0002	0.0605	CbGdCrCtD
Cladribine—POLE2—Daunorubicin—Doxorubicin—uterine cancer	0.00019	0.0576	CbGdCrCtD
Cladribine—POLE2—Idarubicin—Doxorubicin—uterine cancer	0.00019	0.0576	CbGdCrCtD
Cladribine—POLE2—Epirubicin—Doxorubicin—uterine cancer	0.00019	0.0576	CbGdCrCtD
Cladribine—PNP—Testosterone Propionate—Progesterone—uterine cancer	0.000188	0.057	CbGdCrCtD
Cladribine—ABCG2—female gonad—uterine cancer	0.000175	0.00212	CbGeAlD
Cladribine—ABCG2—vagina—uterine cancer	0.000174	0.0021	CbGeAlD
Cladribine—POLA1—Levonorgestrel—Progesterone—uterine cancer	0.000159	0.0481	CbGdCrCtD
Cladribine—PNP—Daunorubicin—Epirubicin—uterine cancer	0.000159	0.048	CbGdCrCtD
Cladribine—PNP—Danazol—Progesterone—uterine cancer	0.000156	0.0474	CbGdCrCtD
Cladribine—PNP—Daunorubicin—Doxorubicin—uterine cancer	0.000147	0.0444	CbGdCrCtD
Cladribine—PNP—Norethindrone—Progesterone—uterine cancer	0.000141	0.0427	CbGdCrCtD
Cladribine—Chills—Etoposide—uterine cancer	0.000117	0.00106	CcSEcCtD
Cladribine—Sepsis—Doxorubicin—uterine cancer	0.000117	0.00106	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000117	0.00105	CcSEcCtD
Cladribine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000116	0.00105	CcSEcCtD
Cladribine—Alopecia—Etoposide—uterine cancer	0.000116	0.00104	CcSEcCtD
Cladribine—Vomiting—Progesterone—uterine cancer	0.000116	0.00104	CcSEcCtD
Cladribine—Renal failure acute—Epirubicin—uterine cancer	0.000115	0.00103	CcSEcCtD
Cladribine—Rash—Progesterone—uterine cancer	0.000115	0.00103	CcSEcCtD
Cladribine—Dermatitis—Progesterone—uterine cancer	0.000114	0.00103	CcSEcCtD
Cladribine—Phlebitis—Doxorubicin—uterine cancer	0.000114	0.00102	CcSEcCtD
Cladribine—Headache—Progesterone—uterine cancer	0.000114	0.00102	CcSEcCtD
Cladribine—ABCG2—lymph node—uterine cancer	0.000113	0.00136	CbGeAlD
Cladribine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000113	0.00101	CcSEcCtD
Cladribine—PNP—Levonorgestrel—Progesterone—uterine cancer	0.000112	0.034	CbGdCrCtD
Cladribine—Decreased appetite—Dactinomycin—uterine cancer	0.000112	0.001	CcSEcCtD
Cladribine—Renal impairment—Epirubicin—uterine cancer	0.000111	0.001	CcSEcCtD
Cladribine—Fatigue—Dactinomycin—uterine cancer	0.000111	0.000996	CcSEcCtD
Cladribine—Back pain—Etoposide—uterine cancer	0.00011	0.000991	CcSEcCtD
Cladribine—Purpura—Epirubicin—uterine cancer	0.00011	0.00099	CcSEcCtD
Cladribine—Pain—Dactinomycin—uterine cancer	0.00011	0.000988	CcSEcCtD
Cladribine—Vascular purpura—Doxorubicin—uterine cancer	0.00011	0.000987	CcSEcCtD
Cladribine—Hepatic failure—Doxorubicin—uterine cancer	0.000109	0.000982	CcSEcCtD
Cladribine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000109	0.00098	CcSEcCtD
Cladribine—Cardiac failure—Epirubicin—uterine cancer	0.000109	0.000977	CcSEcCtD
Cladribine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000108	0.000973	CcSEcCtD
Cladribine—Lethargy—Epirubicin—uterine cancer	0.000108	0.000973	CcSEcCtD
Cladribine—Nausea—Progesterone—uterine cancer	0.000108	0.000971	CcSEcCtD
Cladribine—Renal failure acute—Doxorubicin—uterine cancer	0.000106	0.000956	CcSEcCtD
Cladribine—Pain in extremity—Epirubicin—uterine cancer	0.000106	0.000954	CcSEcCtD
Cladribine—Feeling abnormal—Dactinomycin—uterine cancer	0.000106	0.000952	CcSEcCtD
Cladribine—Ill-defined disorder—Etoposide—uterine cancer	0.000106	0.000951	CcSEcCtD
Cladribine—Anaemia—Etoposide—uterine cancer	0.000105	0.000947	CcSEcCtD
Cladribine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000105	0.000945	CcSEcCtD
Cladribine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000105	0.000942	CcSEcCtD
Cladribine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000104	0.000934	CcSEcCtD
Cladribine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000104	0.000933	CcSEcCtD
Cladribine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000103	0.000928	CcSEcCtD
Cladribine—Renal impairment—Doxorubicin—uterine cancer	0.000103	0.000927	CcSEcCtD
Cladribine—Malaise—Etoposide—uterine cancer	0.000103	0.000924	CcSEcCtD
Cladribine—Purpura—Doxorubicin—uterine cancer	0.000102	0.000916	CcSEcCtD
Cladribine—Abdominal pain—Dactinomycin—uterine cancer	0.000102	0.000914	CcSEcCtD
Cladribine—Body temperature increased—Dactinomycin—uterine cancer	0.000102	0.000914	CcSEcCtD
Cladribine—Cardiac failure—Doxorubicin—uterine cancer	0.000101	0.000904	CcSEcCtD
Cladribine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.0001	0.000901	CcSEcCtD
Cladribine—Lethargy—Doxorubicin—uterine cancer	0.0001	0.000901	CcSEcCtD
Cladribine—Ataxia—Epirubicin—uterine cancer	9.97e-05	0.000897	CcSEcCtD
Cladribine—Cough—Etoposide—uterine cancer	9.94e-05	0.000894	CcSEcCtD
Cladribine—Pain in extremity—Doxorubicin—uterine cancer	9.81e-05	0.000883	CcSEcCtD
Cladribine—Nausea—Medroxyprogesterone Acetate—uterine cancer	9.78e-05	0.00088	CcSEcCtD
Cladribine—Chest pain—Etoposide—uterine cancer	9.7e-05	0.000873	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	9.63e-05	0.000866	CcSEcCtD
Cladribine—Discomfort—Etoposide—uterine cancer	9.58e-05	0.000862	CcSEcCtD
Cladribine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	9.55e-05	0.000859	CcSEcCtD
Cladribine—Hypersensitivity—Dactinomycin—uterine cancer	9.46e-05	0.000851	CcSEcCtD
Cladribine—Confusional state—Etoposide—uterine cancer	9.37e-05	0.000843	CcSEcCtD
Cladribine—Muscular weakness—Epirubicin—uterine cancer	9.35e-05	0.000841	CcSEcCtD
Cladribine—DCK—Doxorubicin—Epirubicin—uterine cancer	9.26e-05	0.028	CbGdCrCtD
Cladribine—Infection—Etoposide—uterine cancer	9.23e-05	0.000831	CcSEcCtD
Cladribine—Ataxia—Doxorubicin—uterine cancer	9.22e-05	0.00083	CcSEcCtD
Cladribine—Asthenia—Dactinomycin—uterine cancer	9.21e-05	0.000829	CcSEcCtD
Cladribine—Thrombocytopenia—Etoposide—uterine cancer	9.1e-05	0.000819	CcSEcCtD
Cladribine—Tachycardia—Etoposide—uterine cancer	9.07e-05	0.000816	CcSEcCtD
Cladribine—Eosinophilia—Epirubicin—uterine cancer	9.07e-05	0.000816	CcSEcCtD
Cladribine—Skin disorder—Etoposide—uterine cancer	9.03e-05	0.000812	CcSEcCtD
Cladribine—Hyperhidrosis—Etoposide—uterine cancer	8.99e-05	0.000809	CcSEcCtD
Cladribine—Anorexia—Etoposide—uterine cancer	8.86e-05	0.000797	CcSEcCtD
Cladribine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	8.83e-05	0.000795	CcSEcCtD
Cladribine—Diarrhoea—Dactinomycin—uterine cancer	8.79e-05	0.000791	CcSEcCtD
Cladribine—Pancytopenia—Epirubicin—uterine cancer	8.7e-05	0.000783	CcSEcCtD
Cladribine—Hypotension—Etoposide—uterine cancer	8.69e-05	0.000782	CcSEcCtD
Cladribine—Muscular weakness—Doxorubicin—uterine cancer	8.65e-05	0.000778	CcSEcCtD
Cladribine—Neutropenia—Epirubicin—uterine cancer	8.57e-05	0.000771	CcSEcCtD
Cladribine—DCK—Epirubicin—Doxorubicin—uterine cancer	8.56e-05	0.026	CbGdCrCtD
Cladribine—Upper respiratory tract infection—Epirubicin—uterine cancer	8.52e-05	0.000766	CcSEcCtD
Cladribine—Eosinophilia—Doxorubicin—uterine cancer	8.39e-05	0.000755	CcSEcCtD
Cladribine—Paraesthesia—Etoposide—uterine cancer	8.35e-05	0.000751	CcSEcCtD
Cladribine—Dyspnoea—Etoposide—uterine cancer	8.29e-05	0.000746	CcSEcCtD
Cladribine—Somnolence—Etoposide—uterine cancer	8.26e-05	0.000744	CcSEcCtD
Cladribine—Pneumonia—Epirubicin—uterine cancer	8.22e-05	0.000739	CcSEcCtD
Cladribine—Infestation NOS—Epirubicin—uterine cancer	8.17e-05	0.000735	CcSEcCtD
Cladribine—Infestation—Epirubicin—uterine cancer	8.17e-05	0.000735	CcSEcCtD
Cladribine—Vomiting—Dactinomycin—uterine cancer	8.17e-05	0.000735	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	8.1e-05	0.000729	CcSEcCtD
Cladribine—Rash—Dactinomycin—uterine cancer	8.1e-05	0.000729	CcSEcCtD
Cladribine—Decreased appetite—Etoposide—uterine cancer	8.08e-05	0.000727	CcSEcCtD
Cladribine—Pancytopenia—Doxorubicin—uterine cancer	8.05e-05	0.000724	CcSEcCtD
Cladribine—Renal failure—Epirubicin—uterine cancer	8.03e-05	0.000723	CcSEcCtD
Cladribine—Gastrointestinal disorder—Etoposide—uterine cancer	8.02e-05	0.000722	CcSEcCtD
Cladribine—Fatigue—Etoposide—uterine cancer	8.01e-05	0.000721	CcSEcCtD
Cladribine—Pain—Etoposide—uterine cancer	7.95e-05	0.000715	CcSEcCtD
Cladribine—Constipation—Etoposide—uterine cancer	7.95e-05	0.000715	CcSEcCtD
Cladribine—Urinary tract infection—Epirubicin—uterine cancer	7.94e-05	0.000715	CcSEcCtD
Cladribine—Conjunctivitis—Epirubicin—uterine cancer	7.94e-05	0.000715	CcSEcCtD
Cladribine—Neutropenia—Doxorubicin—uterine cancer	7.93e-05	0.000713	CcSEcCtD
Cladribine—Upper respiratory tract infection—Doxorubicin—uterine cancer	7.88e-05	0.000709	CcSEcCtD
Cladribine—Hepatobiliary disease—Epirubicin—uterine cancer	7.73e-05	0.000695	CcSEcCtD
Cladribine—Epistaxis—Epirubicin—uterine cancer	7.71e-05	0.000693	CcSEcCtD
Cladribine—Feeling abnormal—Etoposide—uterine cancer	7.66e-05	0.000689	CcSEcCtD
Cladribine—Nausea—Dactinomycin—uterine cancer	7.63e-05	0.000686	CcSEcCtD
Cladribine—Pneumonia—Doxorubicin—uterine cancer	7.6e-05	0.000684	CcSEcCtD
Cladribine—Gastrointestinal pain—Etoposide—uterine cancer	7.6e-05	0.000684	CcSEcCtD
Cladribine—Infestation NOS—Doxorubicin—uterine cancer	7.56e-05	0.00068	CcSEcCtD
Cladribine—Infestation—Doxorubicin—uterine cancer	7.56e-05	0.00068	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	7.49e-05	0.000674	CcSEcCtD
Cladribine—Renal failure—Doxorubicin—uterine cancer	7.43e-05	0.000669	CcSEcCtD
Cladribine—Urticaria—Etoposide—uterine cancer	7.38e-05	0.000664	CcSEcCtD
Cladribine—Haemoglobin—Epirubicin—uterine cancer	7.37e-05	0.000663	CcSEcCtD
Cladribine—Body temperature increased—Etoposide—uterine cancer	7.35e-05	0.000661	CcSEcCtD
Cladribine—Abdominal pain—Etoposide—uterine cancer	7.35e-05	0.000661	CcSEcCtD
Cladribine—Urinary tract infection—Doxorubicin—uterine cancer	7.35e-05	0.000661	CcSEcCtD
Cladribine—Conjunctivitis—Doxorubicin—uterine cancer	7.35e-05	0.000661	CcSEcCtD
Cladribine—Haemorrhage—Epirubicin—uterine cancer	7.33e-05	0.00066	CcSEcCtD
Cladribine—Pharyngitis—Epirubicin—uterine cancer	7.28e-05	0.000655	CcSEcCtD
Cladribine—Urinary tract disorder—Epirubicin—uterine cancer	7.24e-05	0.000652	CcSEcCtD
Cladribine—Oedema peripheral—Epirubicin—uterine cancer	7.22e-05	0.00065	CcSEcCtD
Cladribine—Connective tissue disorder—Epirubicin—uterine cancer	7.21e-05	0.000648	CcSEcCtD
Cladribine—Urethral disorder—Epirubicin—uterine cancer	7.19e-05	0.000647	CcSEcCtD
Cladribine—Hepatobiliary disease—Doxorubicin—uterine cancer	7.15e-05	0.000643	CcSEcCtD
Cladribine—Epistaxis—Doxorubicin—uterine cancer	7.13e-05	0.000642	CcSEcCtD
Cladribine—SLC22A2—Neuronal System—ABCC9—uterine cancer	7.03e-05	0.000721	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—NDC80—uterine cancer	7.03e-05	0.00072	CbGpPWpGaD
Cladribine—POLE—S Phase—CDKN1B—uterine cancer	7.02e-05	0.000719	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—RRM2—uterine cancer	6.99e-05	0.000717	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP11A1—uterine cancer	6.98e-05	0.000715	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	6.94e-05	0.000712	CbGpPWpGaD
Cladribine—Erythema multiforme—Epirubicin—uterine cancer	6.93e-05	0.000624	CcSEcCtD
Cladribine—Eye disorder—Epirubicin—uterine cancer	6.85e-05	0.000617	CcSEcCtD
Cladribine—Hypersensitivity—Etoposide—uterine cancer	6.85e-05	0.000616	CcSEcCtD
Cladribine—Haemoglobin—Doxorubicin—uterine cancer	6.82e-05	0.000614	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—SMAD3—uterine cancer	6.81e-05	0.000698	CbGpPWpGaD
Cladribine—Cardiac disorder—Epirubicin—uterine cancer	6.81e-05	0.000612	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	6.79e-05	0.000696	CbGpPWpGaD
Cladribine—Haemorrhage—Doxorubicin—uterine cancer	6.79e-05	0.000611	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.74e-05	0.000691	CbGpPWpGaD
Cladribine—Pharyngitis—Doxorubicin—uterine cancer	6.73e-05	0.000606	CcSEcCtD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—EP300—uterine cancer	6.72e-05	0.000688	CbGpPWpGaD
Cladribine—Urinary tract disorder—Doxorubicin—uterine cancer	6.7e-05	0.000603	CcSEcCtD
Cladribine—Oedema peripheral—Doxorubicin—uterine cancer	6.68e-05	0.000602	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—POLD1—uterine cancer	6.68e-05	0.000685	CbGpPWpGaD
Cladribine—Asthenia—Etoposide—uterine cancer	6.67e-05	0.0006	CcSEcCtD
Cladribine—Connective tissue disorder—Doxorubicin—uterine cancer	6.67e-05	0.0006	CcSEcCtD
Cladribine—POLA1—E2F transcription factor network—EP300—uterine cancer	6.67e-05	0.000683	CbGpPWpGaD
Cladribine—Angiopathy—Epirubicin—uterine cancer	6.65e-05	0.000599	CcSEcCtD
Cladribine—Urethral disorder—Doxorubicin—uterine cancer	6.65e-05	0.000599	CcSEcCtD
Cladribine—Immune system disorder—Epirubicin—uterine cancer	6.62e-05	0.000596	CcSEcCtD
Cladribine—PNP—Metabolism—RRM2—uterine cancer	6.62e-05	0.000678	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SRD5A2—uterine cancer	6.62e-05	0.000678	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NDUFB11—uterine cancer	6.62e-05	0.000678	CbGpPWpGaD
Cladribine—Mediastinal disorder—Epirubicin—uterine cancer	6.61e-05	0.000595	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	6.6e-05	0.000676	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKR1C3—uterine cancer	6.59e-05	0.000676	CbGpPWpGaD
Cladribine—Chills—Epirubicin—uterine cancer	6.58e-05	0.000592	CcSEcCtD
Cladribine—Pruritus—Etoposide—uterine cancer	6.58e-05	0.000592	CcSEcCtD
Cladribine—SLC22A1—Neuronal System—ABCC9—uterine cancer	6.55e-05	0.000672	CbGpPWpGaD
Cladribine—Arrhythmia—Epirubicin—uterine cancer	6.55e-05	0.00059	CcSEcCtD
Cladribine—DCK—Levonorgestrel—Progesterone—uterine cancer	6.55e-05	0.0198	CbGdCrCtD
Cladribine—POLE2—Cell Cycle—CDKN2B—uterine cancer	6.55e-05	0.000671	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—YWHAE—uterine cancer	6.54e-05	0.00067	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	6.51e-05	0.000668	CbGpPWpGaD
Cladribine—Alopecia—Epirubicin—uterine cancer	6.48e-05	0.000583	CcSEcCtD
Cladribine—RRM2—Cell Cycle—MLH1—uterine cancer	6.47e-05	0.000663	CbGpPWpGaD
Cladribine—Mental disorder—Epirubicin—uterine cancer	6.42e-05	0.000578	CcSEcCtD
Cladribine—PNP—Metabolism—DCN—uterine cancer	6.42e-05	0.000658	CbGpPWpGaD
Cladribine—Erythema multiforme—Doxorubicin—uterine cancer	6.42e-05	0.000577	CcSEcCtD
Cladribine—Erythema—Epirubicin—uterine cancer	6.38e-05	0.000574	CcSEcCtD
Cladribine—Malnutrition—Epirubicin—uterine cancer	6.38e-05	0.000574	CcSEcCtD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—uterine cancer	6.36e-05	0.000652	CbGpPWpGaD
Cladribine—Diarrhoea—Etoposide—uterine cancer	6.36e-05	0.000572	CcSEcCtD
Cladribine—Eye disorder—Doxorubicin—uterine cancer	6.34e-05	0.000571	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—BIRC5—uterine cancer	6.32e-05	0.000647	CbGpPWpGaD
Cladribine—Cardiac disorder—Doxorubicin—uterine cancer	6.3e-05	0.000567	CcSEcCtD
Cladribine—Flatulence—Epirubicin—uterine cancer	6.29e-05	0.000566	CcSEcCtD
Cladribine—POLE—Cell Cycle, Mitotic—YWHAE—uterine cancer	6.28e-05	0.000644	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	6.24e-05	0.00064	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MLH1—uterine cancer	6.21e-05	0.000636	CbGpPWpGaD
Cladribine—DCK—Metabolism—SRD5A2—uterine cancer	6.18e-05	0.000634	CbGpPWpGaD
Cladribine—DCK—Metabolism—NDUFB11—uterine cancer	6.18e-05	0.000634	CbGpPWpGaD
Cladribine—Back pain—Epirubicin—uterine cancer	6.18e-05	0.000556	CcSEcCtD
Cladribine—Angiopathy—Doxorubicin—uterine cancer	6.16e-05	0.000554	CcSEcCtD
Cladribine—Dizziness—Etoposide—uterine cancer	6.15e-05	0.000553	CcSEcCtD
Cladribine—Immune system disorder—Doxorubicin—uterine cancer	6.13e-05	0.000552	CcSEcCtD
Cladribine—Mediastinal disorder—Doxorubicin—uterine cancer	6.12e-05	0.00055	CcSEcCtD
Cladribine—POLA1—Synthesis of DNA—CDKN1B—uterine cancer	6.1e-05	0.000625	CbGpPWpGaD
Cladribine—Chills—Doxorubicin—uterine cancer	6.09e-05	0.000548	CcSEcCtD
Cladribine—Arrhythmia—Doxorubicin—uterine cancer	6.06e-05	0.000545	CcSEcCtD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	6.06e-05	0.000621	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP11A1—uterine cancer	6.05e-05	0.00062	CbGpPWpGaD
Cladribine—Alopecia—Doxorubicin—uterine cancer	6e-05	0.00054	CcSEcCtD
Cladribine—POLA1—Cell Cycle—POLD1—uterine cancer	5.98e-05	0.000613	CbGpPWpGaD
Cladribine—Mental disorder—Doxorubicin—uterine cancer	5.94e-05	0.000535	CcSEcCtD
Cladribine—Ill-defined disorder—Epirubicin—uterine cancer	5.92e-05	0.000533	CcSEcCtD
Cladribine—Vomiting—Etoposide—uterine cancer	5.91e-05	0.000532	CcSEcCtD
Cladribine—Erythema—Doxorubicin—uterine cancer	5.91e-05	0.000532	CcSEcCtD
Cladribine—Malnutrition—Doxorubicin—uterine cancer	5.91e-05	0.000532	CcSEcCtD
Cladribine—NR5A1—Generic Transcription Pathway—ESR1—uterine cancer	5.9e-05	0.000605	CbGpPWpGaD
Cladribine—Anaemia—Epirubicin—uterine cancer	5.9e-05	0.000531	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.9e-05	0.000604	CbGpPWpGaD
Cladribine—Rash—Etoposide—uterine cancer	5.86e-05	0.000527	CcSEcCtD
Cladribine—Dermatitis—Etoposide—uterine cancer	5.86e-05	0.000527	CcSEcCtD
Cladribine—RRM2—Cell Cycle—YWHAE—uterine cancer	5.85e-05	0.000599	CbGpPWpGaD
Cladribine—Headache—Etoposide—uterine cancer	5.82e-05	0.000524	CcSEcCtD
Cladribine—Flatulence—Doxorubicin—uterine cancer	5.82e-05	0.000524	CcSEcCtD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	5.82e-05	0.000596	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKR1B1—uterine cancer	5.81e-05	0.000595	CbGpPWpGaD
Cladribine—RRM1—Metabolism—STAR—uterine cancer	5.81e-05	0.000595	CbGpPWpGaD
Cladribine—Malaise—Epirubicin—uterine cancer	5.76e-05	0.000518	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.75e-05	0.000589	CbGpPWpGaD
Cladribine—POLA1—DNA Replication—CDKN1B—uterine cancer	5.72e-05	0.000586	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKR1C3—uterine cancer	5.72e-05	0.000586	CbGpPWpGaD
Cladribine—Back pain—Doxorubicin—uterine cancer	5.71e-05	0.000514	CcSEcCtD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	5.71e-05	0.000585	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	5.66e-05	0.00058	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—BIRC5—uterine cancer	5.65e-05	0.000579	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—YWHAE—uterine cancer	5.61e-05	0.000575	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—MET—uterine cancer	5.58e-05	0.000572	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—RRM2—uterine cancer	5.57e-05	0.000571	CbGpPWpGaD
Cladribine—Cough—Epirubicin—uterine cancer	5.57e-05	0.000501	CcSEcCtD
Cladribine—Nausea—Etoposide—uterine cancer	5.52e-05	0.000497	CcSEcCtD
Cladribine—POLA1—G1/S Transition—CDKN1B—uterine cancer	5.51e-05	0.000565	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.48e-05	0.000562	CbGpPWpGaD
Cladribine—Ill-defined disorder—Doxorubicin—uterine cancer	5.48e-05	0.000493	CcSEcCtD
Cladribine—Anaemia—Doxorubicin—uterine cancer	5.46e-05	0.000491	CcSEcCtD
Cladribine—POLE—Mitotic M-M/G1 phases—BIRC5—uterine cancer	5.44e-05	0.000558	CbGpPWpGaD
Cladribine—Arthralgia—Epirubicin—uterine cancer	5.44e-05	0.000489	CcSEcCtD
Cladribine—Myalgia—Epirubicin—uterine cancer	5.44e-05	0.000489	CcSEcCtD
Cladribine—Chest pain—Epirubicin—uterine cancer	5.44e-05	0.000489	CcSEcCtD
Cladribine—Anxiety—Epirubicin—uterine cancer	5.42e-05	0.000487	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	5.4e-05	0.000486	CcSEcCtD
Cladribine—Discomfort—Epirubicin—uterine cancer	5.37e-05	0.000483	CcSEcCtD
Cladribine—Malaise—Doxorubicin—uterine cancer	5.33e-05	0.000479	CcSEcCtD
Cladribine—NR5A1—Gene Expression—PGR—uterine cancer	5.32e-05	0.000546	CbGpPWpGaD
Cladribine—Confusional state—Epirubicin—uterine cancer	5.25e-05	0.000473	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	5.24e-05	0.000537	CbGpPWpGaD
Cladribine—Oedema—Epirubicin—uterine cancer	5.21e-05	0.000469	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.19e-05	0.000532	CbGpPWpGaD
Cladribine—Infection—Epirubicin—uterine cancer	5.18e-05	0.000466	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	5.17e-05	0.00053	CbGpPWpGaD
Cladribine—Cough—Doxorubicin—uterine cancer	5.15e-05	0.000464	CcSEcCtD
Cladribine—RRM2B—Metabolism—CYP19A1—uterine cancer	5.14e-05	0.000526	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—STK11—uterine cancer	5.14e-05	0.000526	CbGpPWpGaD
Cladribine—Nervous system disorder—Epirubicin—uterine cancer	5.11e-05	0.00046	CcSEcCtD
Cladribine—Thrombocytopenia—Epirubicin—uterine cancer	5.1e-05	0.000459	CcSEcCtD
Cladribine—Tachycardia—Epirubicin—uterine cancer	5.09e-05	0.000458	CcSEcCtD
Cladribine—Skin disorder—Epirubicin—uterine cancer	5.06e-05	0.000455	CcSEcCtD
Cladribine—NR5A1—Gene Expression—EZH2—uterine cancer	5.06e-05	0.000518	CbGpPWpGaD
Cladribine—Hyperhidrosis—Epirubicin—uterine cancer	5.04e-05	0.000453	CcSEcCtD
Cladribine—Myalgia—Doxorubicin—uterine cancer	5.03e-05	0.000453	CcSEcCtD
Cladribine—Arthralgia—Doxorubicin—uterine cancer	5.03e-05	0.000453	CcSEcCtD
Cladribine—Chest pain—Doxorubicin—uterine cancer	5.03e-05	0.000453	CcSEcCtD
Cladribine—Anxiety—Doxorubicin—uterine cancer	5.01e-05	0.000451	CcSEcCtD
Cladribine—POLA1—S Phase—CDKN1B—uterine cancer	5e-05	0.000512	CbGpPWpGaD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.99e-05	0.000449	CcSEcCtD
Cladribine—POLA1—Cell Cycle—RRM2—uterine cancer	4.98e-05	0.000511	CbGpPWpGaD
Cladribine—Discomfort—Doxorubicin—uterine cancer	4.97e-05	0.000447	CcSEcCtD
Cladribine—Anorexia—Epirubicin—uterine cancer	4.97e-05	0.000447	CcSEcCtD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—uterine cancer	4.92e-05	0.000504	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4.91e-05	0.000504	CbGpPWpGaD
Cladribine—Hypotension—Epirubicin—uterine cancer	4.87e-05	0.000438	CcSEcCtD
Cladribine—Confusional state—Doxorubicin—uterine cancer	4.86e-05	0.000437	CcSEcCtD
Cladribine—Oedema—Doxorubicin—uterine cancer	4.82e-05	0.000434	CcSEcCtD
Cladribine—Infection—Doxorubicin—uterine cancer	4.79e-05	0.000431	CcSEcCtD
Cladribine—RRM2—Metabolism—AKR1B1—uterine cancer	4.78e-05	0.00049	CbGpPWpGaD
Cladribine—RRM2—Metabolism—STAR—uterine cancer	4.78e-05	0.00049	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.75e-05	0.000427	CcSEcCtD
Cladribine—Nervous system disorder—Doxorubicin—uterine cancer	4.73e-05	0.000425	CcSEcCtD
Cladribine—Thrombocytopenia—Doxorubicin—uterine cancer	4.72e-05	0.000425	CcSEcCtD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4.72e-05	0.000483	CbGpPWpGaD
Cladribine—Insomnia—Epirubicin—uterine cancer	4.71e-05	0.000424	CcSEcCtD
Cladribine—Tachycardia—Doxorubicin—uterine cancer	4.71e-05	0.000423	CcSEcCtD
Cladribine—NR5A1—Gene Expression—ESR2—uterine cancer	4.69e-05	0.00048	CbGpPWpGaD
Cladribine—Skin disorder—Doxorubicin—uterine cancer	4.68e-05	0.000421	CcSEcCtD
Cladribine—Paraesthesia—Epirubicin—uterine cancer	4.68e-05	0.000421	CcSEcCtD
Cladribine—Hyperhidrosis—Doxorubicin—uterine cancer	4.66e-05	0.000419	CcSEcCtD
Cladribine—Dyspnoea—Epirubicin—uterine cancer	4.65e-05	0.000418	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	4.64e-05	0.000476	CbGpPWpGaD
Cladribine—Somnolence—Epirubicin—uterine cancer	4.63e-05	0.000417	CcSEcCtD
Cladribine—Anorexia—Doxorubicin—uterine cancer	4.6e-05	0.000414	CcSEcCtD
Cladribine—RRM1—Metabolism—POLD1—uterine cancer	4.56e-05	0.000467	CbGpPWpGaD
Cladribine—Decreased appetite—Epirubicin—uterine cancer	4.53e-05	0.000408	CcSEcCtD
Cladribine—Hypotension—Doxorubicin—uterine cancer	4.5e-05	0.000405	CcSEcCtD
Cladribine—Gastrointestinal disorder—Epirubicin—uterine cancer	4.5e-05	0.000405	CcSEcCtD
Cladribine—Fatigue—Epirubicin—uterine cancer	4.49e-05	0.000404	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—YWHAE—uterine cancer	4.47e-05	0.000459	CbGpPWpGaD
Cladribine—DCK—Metabolism—STAR—uterine cancer	4.47e-05	0.000458	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKR1B1—uterine cancer	4.47e-05	0.000458	CbGpPWpGaD
Cladribine—Constipation—Epirubicin—uterine cancer	4.46e-05	0.000401	CcSEcCtD
Cladribine—Pain—Epirubicin—uterine cancer	4.46e-05	0.000401	CcSEcCtD
Cladribine—PNP—Metabolism—CYP19A1—uterine cancer	4.45e-05	0.000456	CbGpPWpGaD
Cladribine—PNP—Metabolism—STK11—uterine cancer	4.45e-05	0.000456	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MLH1—uterine cancer	4.42e-05	0.000453	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.41e-05	0.000452	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN2B—uterine cancer	4.39e-05	0.00045	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.39e-05	0.000395	CcSEcCtD
Cladribine—Insomnia—Doxorubicin—uterine cancer	4.36e-05	0.000392	CcSEcCtD
Cladribine—Paraesthesia—Doxorubicin—uterine cancer	4.33e-05	0.00039	CcSEcCtD
Cladribine—Dyspnoea—Doxorubicin—uterine cancer	4.3e-05	0.000387	CcSEcCtD
Cladribine—Feeling abnormal—Epirubicin—uterine cancer	4.29e-05	0.000386	CcSEcCtD
Cladribine—Somnolence—Doxorubicin—uterine cancer	4.29e-05	0.000386	CcSEcCtD
Cladribine—RRM1—Metabolism—AKR1C1—uterine cancer	4.26e-05	0.000437	CbGpPWpGaD
Cladribine—Gastrointestinal pain—Epirubicin—uterine cancer	4.26e-05	0.000383	CcSEcCtD
Cladribine—RRM2—Cell Cycle, Mitotic—BIRC5—uterine cancer	4.24e-05	0.000435	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2B—uterine cancer	4.22e-05	0.000432	CbGpPWpGaD
Cladribine—Decreased appetite—Doxorubicin—uterine cancer	4.19e-05	0.000377	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN2A—uterine cancer	4.19e-05	0.000429	CbGpPWpGaD
Cladribine—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.16e-05	0.000375	CcSEcCtD
Cladribine—Fatigue—Doxorubicin—uterine cancer	4.16e-05	0.000374	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	4.15e-05	0.000425	CbGpPWpGaD
Cladribine—Urticaria—Epirubicin—uterine cancer	4.14e-05	0.000372	CcSEcCtD
Cladribine—Pain—Doxorubicin—uterine cancer	4.12e-05	0.000371	CcSEcCtD
Cladribine—Constipation—Doxorubicin—uterine cancer	4.12e-05	0.000371	CcSEcCtD
Cladribine—Abdominal pain—Epirubicin—uterine cancer	4.12e-05	0.000371	CcSEcCtD
Cladribine—Body temperature increased—Epirubicin—uterine cancer	4.12e-05	0.000371	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—ERBB2—uterine cancer	4.08e-05	0.000418	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—BIRC5—uterine cancer	4.07e-05	0.000417	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.06e-05	0.000416	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—YWHAE—uterine cancer	4e-05	0.00041	CbGpPWpGaD
Cladribine—Feeling abnormal—Doxorubicin—uterine cancer	3.97e-05	0.000357	CcSEcCtD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.95e-05	0.000405	CbGpPWpGaD
Cladribine—Gastrointestinal pain—Doxorubicin—uterine cancer	3.94e-05	0.000355	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.92e-05	0.000402	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—BIRC5—uterine cancer	3.88e-05	0.000397	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—MTHFR—uterine cancer	3.86e-05	0.000395	CbGpPWpGaD
Cladribine—Hypersensitivity—Epirubicin—uterine cancer	3.84e-05	0.000345	CcSEcCtD
Cladribine—Urticaria—Doxorubicin—uterine cancer	3.83e-05	0.000345	CcSEcCtD
Cladribine—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.82e-05	0.000391	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—CDKN2B—uterine cancer	3.82e-05	0.000391	CbGpPWpGaD
Cladribine—Abdominal pain—Doxorubicin—uterine cancer	3.81e-05	0.000343	CcSEcCtD
Cladribine—Body temperature increased—Doxorubicin—uterine cancer	3.81e-05	0.000343	CcSEcCtD
Cladribine—RRM1—Metabolism—RRM2—uterine cancer	3.8e-05	0.000389	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.8e-05	0.000389	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—BIRC5—uterine cancer	3.79e-05	0.000389	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.78e-05	0.000387	CbGpPWpGaD
Cladribine—RRM2—Metabolism—POLD1—uterine cancer	3.75e-05	0.000385	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN2A—uterine cancer	3.74e-05	0.000384	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.74e-05	0.000383	CbGpPWpGaD
Cladribine—Asthenia—Epirubicin—uterine cancer	3.74e-05	0.000336	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN1B—uterine cancer	3.71e-05	0.00038	CbGpPWpGaD
Cladribine—RRM1—Metabolism—DCN—uterine cancer	3.69e-05	0.000378	CbGpPWpGaD
Cladribine—Pruritus—Epirubicin—uterine cancer	3.69e-05	0.000332	CcSEcCtD
Cladribine—POLE—Cell Cycle—BIRC5—uterine cancer	3.64e-05	0.000373	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—CTNNB1—uterine cancer	3.57e-05	0.000366	CbGpPWpGaD
Cladribine—Diarrhoea—Epirubicin—uterine cancer	3.56e-05	0.000321	CcSEcCtD
Cladribine—Hypersensitivity—Doxorubicin—uterine cancer	3.55e-05	0.00032	CcSEcCtD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.52e-05	0.000361	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	3.52e-05	0.00036	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKR1C1—uterine cancer	3.51e-05	0.00036	CbGpPWpGaD
Cladribine—DCK—Metabolism—POLD1—uterine cancer	3.51e-05	0.00036	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—SMAD3—uterine cancer	3.48e-05	0.000357	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP11A1—uterine cancer	3.48e-05	0.000356	CbGpPWpGaD
Cladribine—Asthenia—Doxorubicin—uterine cancer	3.46e-05	0.000311	CcSEcCtD
Cladribine—Dizziness—Epirubicin—uterine cancer	3.45e-05	0.00031	CcSEcCtD
Cladribine—Pruritus—Doxorubicin—uterine cancer	3.41e-05	0.000307	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	3.36e-05	0.000344	CbGpPWpGaD
Cladribine—PNP—Metabolism—MTHFR—uterine cancer	3.35e-05	0.000343	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.32e-05	0.00034	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—EP300—uterine cancer	3.32e-05	0.00034	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN1B—uterine cancer	3.32e-05	0.00034	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.31e-05	0.00034	CbGpPWpGaD
Cladribine—Vomiting—Epirubicin—uterine cancer	3.31e-05	0.000298	CcSEcCtD
Cladribine—Diarrhoea—Doxorubicin—uterine cancer	3.3e-05	0.000297	CcSEcCtD
Cladribine—Rash—Epirubicin—uterine cancer	3.29e-05	0.000296	CcSEcCtD
Cladribine—RRM1—Metabolism—AKR1C3—uterine cancer	3.28e-05	0.000336	CbGpPWpGaD
Cladribine—Dermatitis—Epirubicin—uterine cancer	3.28e-05	0.000295	CcSEcCtD
Cladribine—DCK—Metabolism—AKR1C1—uterine cancer	3.28e-05	0.000336	CbGpPWpGaD
Cladribine—Headache—Epirubicin—uterine cancer	3.26e-05	0.000294	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—EP300—uterine cancer	3.26e-05	0.000334	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.24e-05	0.000332	CbGpPWpGaD
Cladribine—Dizziness—Doxorubicin—uterine cancer	3.19e-05	0.000287	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—VEGFA—uterine cancer	3.14e-05	0.000322	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—NRAS—uterine cancer	3.1e-05	0.000318	CbGpPWpGaD
Cladribine—Nausea—Epirubicin—uterine cancer	3.09e-05	0.000278	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.09e-05	0.000316	CbGpPWpGaD
Cladribine—Vomiting—Doxorubicin—uterine cancer	3.07e-05	0.000276	CcSEcCtD
Cladribine—Rash—Doxorubicin—uterine cancer	3.04e-05	0.000274	CcSEcCtD
Cladribine—RRM2—Metabolism—DCN—uterine cancer	3.04e-05	0.000311	CbGpPWpGaD
Cladribine—Dermatitis—Doxorubicin—uterine cancer	3.04e-05	0.000273	CcSEcCtD
Cladribine—Headache—Doxorubicin—uterine cancer	3.02e-05	0.000272	CcSEcCtD
Cladribine—POLA1—Cell Cycle—CDKN2B—uterine cancer	3.01e-05	0.000308	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.92e-05	0.0003	CbGpPWpGaD
Cladribine—DCK—Metabolism—RRM2—uterine cancer	2.92e-05	0.0003	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—EP300—uterine cancer	2.91e-05	0.000298	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—BIRC5—uterine cancer	2.9e-05	0.000297	CbGpPWpGaD
Cladribine—Nausea—Doxorubicin—uterine cancer	2.86e-05	0.000258	CcSEcCtD
Cladribine—RRM2—Metabolism—CYP11A1—uterine cancer	2.86e-05	0.000293	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—ESR1—uterine cancer	2.84e-05	0.000291	CbGpPWpGaD
Cladribine—DCK—Metabolism—DCN—uterine cancer	2.84e-05	0.000291	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.81e-05	0.000288	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKR1C3—uterine cancer	2.7e-05	0.000277	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.7e-05	0.000276	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP11A1—uterine cancer	2.67e-05	0.000274	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—KRAS—uterine cancer	2.67e-05	0.000274	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—BIRC5—uterine cancer	2.59e-05	0.000266	CbGpPWpGaD
Cladribine—RRM1—Metabolism—STK11—uterine cancer	2.56e-05	0.000262	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP19A1—uterine cancer	2.56e-05	0.000262	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKR1C3—uterine cancer	2.53e-05	0.000259	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN2A—uterine cancer	2.51e-05	0.000258	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.49e-05	0.000255	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.49e-05	0.000255	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NDUFB11—uterine cancer	2.47e-05	0.000254	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SRD5A2—uterine cancer	2.47e-05	0.000254	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SRD5A2—uterine cancer	2.45e-05	0.000251	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NDUFB11—uterine cancer	2.45e-05	0.000251	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2A—uterine cancer	2.41e-05	0.000247	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.39e-05	0.000245	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.39e-05	0.000245	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.28e-05	0.000234	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NDUFB11—uterine cancer	2.28e-05	0.000234	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SRD5A2—uterine cancer	2.28e-05	0.000234	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—HRAS—uterine cancer	2.27e-05	0.000233	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1B—uterine cancer	2.23e-05	0.000228	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.21e-05	0.000226	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—EP300—uterine cancer	2.19e-05	0.000224	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTEN—uterine cancer	2.15e-05	0.00022	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1B—uterine cancer	2.14e-05	0.000219	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP19A1—uterine cancer	2.11e-05	0.000216	CbGpPWpGaD
Cladribine—RRM2—Metabolism—STK11—uterine cancer	2.11e-05	0.000216	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—EP300—uterine cancer	2.1e-05	0.000215	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—uterine cancer	2.08e-05	0.000214	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—EP300—uterine cancer	2.05e-05	0.00021	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—AKT1—uterine cancer	2e-05	0.000205	CbGpPWpGaD
Cladribine—DCK—Metabolism—STK11—uterine cancer	1.97e-05	0.000202	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP19A1—uterine cancer	1.97e-05	0.000202	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—EP300—uterine cancer	1.95e-05	0.0002	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	1.92e-05	0.000197	CbGpPWpGaD
Cladribine—RRM1—Metabolism—MTHFR—uterine cancer	1.92e-05	0.000197	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—EP300—uterine cancer	1.88e-05	0.000192	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.87e-05	0.000191	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTEN—uterine cancer	1.86e-05	0.000191	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1B1—uterine cancer	1.79e-05	0.000183	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—STAR—uterine cancer	1.79e-05	0.000183	CbGpPWpGaD
Cladribine—PNP—Metabolism—EP300—uterine cancer	1.78e-05	0.000182	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1B1—uterine cancer	1.77e-05	0.000181	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—STAR—uterine cancer	1.77e-05	0.000181	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2A—uterine cancer	1.72e-05	0.000176	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	1.7e-05	0.000174	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1B1—uterine cancer	1.65e-05	0.000169	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—STAR—uterine cancer	1.65e-05	0.000169	CbGpPWpGaD
Cladribine—RRM2—Metabolism—MTHFR—uterine cancer	1.58e-05	0.000162	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1B—uterine cancer	1.52e-05	0.000156	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CA—uterine cancer	1.51e-05	0.000155	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—EP300—uterine cancer	1.49e-05	0.000153	CbGpPWpGaD
Cladribine—DCK—Metabolism—MTHFR—uterine cancer	1.48e-05	0.000152	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—POLD1—uterine cancer	1.4e-05	0.000144	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—uterine cancer	1.4e-05	0.000143	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—POLD1—uterine cancer	1.39e-05	0.000142	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—uterine cancer	1.34e-05	0.000138	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—EP300—uterine cancer	1.34e-05	0.000137	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CA—uterine cancer	1.31e-05	0.000135	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1C1—uterine cancer	1.31e-05	0.000135	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1C1—uterine cancer	1.3e-05	0.000133	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—POLD1—uterine cancer	1.29e-05	0.000133	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—uterine cancer	1.24e-05	0.000127	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1C1—uterine cancer	1.21e-05	0.000124	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—RRM2—uterine cancer	1.17e-05	0.00012	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—RRM2—uterine cancer	1.16e-05	0.000119	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—DCN—uterine cancer	1.14e-05	0.000116	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—DCN—uterine cancer	1.12e-05	0.000115	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.1e-05	0.000113	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—RRM2—uterine cancer	1.08e-05	0.000111	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—uterine cancer	1.07e-05	0.00011	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP11A1—uterine cancer	1.07e-05	0.00011	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTEN—uterine cancer	1.07e-05	0.00011	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP11A1—uterine cancer	1.06e-05	0.000109	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—DCN—uterine cancer	1.05e-05	0.000107	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	1.03e-05	0.000105	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—uterine cancer	1.03e-05	0.000105	CbGpPWpGaD
Cladribine—RRM1—Metabolism—EP300—uterine cancer	1.02e-05	0.000104	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1C3—uterine cancer	1.01e-05	0.000104	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1C3—uterine cancer	1e-05	0.000103	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP11A1—uterine cancer	9.87e-06	0.000101	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—uterine cancer	9.57e-06	9.8e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1C3—uterine cancer	9.32e-06	9.56e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTEN—uterine cancer	8.8e-06	9.02e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—HRAS—uterine cancer	8.45e-06	8.66e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—EP300—uterine cancer	8.4e-06	8.6e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTEN—uterine cancer	8.23e-06	8.43e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—STK11—uterine cancer	7.88e-06	8.07e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP19A1—uterine cancer	7.88e-06	8.07e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—HRAS—uterine cancer	7.87e-06	8.07e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—EP300—uterine cancer	7.85e-06	8.04e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—STK11—uterine cancer	7.79e-06	7.99e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP19A1—uterine cancer	7.79e-06	7.99e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CA—uterine cancer	7.54e-06	7.73e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—STK11—uterine cancer	7.26e-06	7.45e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP19A1—uterine cancer	7.26e-06	7.45e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CA—uterine cancer	6.21e-06	6.37e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—uterine cancer	6.16e-06	6.31e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTHFR—uterine cancer	5.92e-06	6.07e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTHFR—uterine cancer	5.86e-06	6e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CA—uterine cancer	5.8e-06	5.95e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTHFR—uterine cancer	5.46e-06	5.59e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—uterine cancer	5.07e-06	5.2e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—uterine cancer	4.74e-06	4.86e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTEN—uterine cancer	3.29e-06	3.37e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTEN—uterine cancer	3.26e-06	3.34e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—EP300—uterine cancer	3.14e-06	3.22e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—EP300—uterine cancer	3.11e-06	3.18e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTEN—uterine cancer	3.04e-06	3.11e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—EP300—uterine cancer	2.9e-06	2.97e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CA—uterine cancer	2.32e-06	2.38e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CA—uterine cancer	2.3e-06	2.36e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CA—uterine cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—uterine cancer	1.9e-06	1.94e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—uterine cancer	1.88e-06	1.92e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—uterine cancer	1.75e-06	1.79e-05	CbGpPWpGaD
